Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: 98%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
54,375
Total Claims
$4.1M
Drug Cost
1,264
Beneficiaries
$3,204
Cost/Patient
Risk Score Breakdown 26/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-15%
Opioid rate vs peers
2.2% vs 2.6% avg
+200%
Cost per patient vs peers
$3,204 vs $1,068 avg
+74%
Brand preference vs peers
15.7% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
2.2%
Opioid Rate
1,188
Opioid Claims
$54K
Opioid Cost
11.1%
Long-Acting Rate
Brand vs Generic
Brand: 8,492 claims · $2.9M
Generic: 45,657 claims · $1.1M
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 1,688 | $462K |
| Valbenazine Tosylate | 82 | $404K |
| Paliperidone Palmitate | 57 | $147K |
| Dextromethorphan Hbr/Quinidine | 152 | $116K |
| Sitagliptin Phosphate | 362 | $107K |
| Empagliflozin | 243 | $77K |
| Rivaroxaban | 269 | $75K |
| Dulaglutide | 106 | $71K |
| Mirabegron | 281 | $68K |
| Insulin Glargine,hum.Rec.Anlog | 190 | $67K |
| Semaglutide | 56 | $56K |
| Insulin Detemir | 144 | $55K |
| Vibegron | 203 | $49K |
| Linaclotide | 106 | $45K |
| Fluticasone/Umeclidin/Vilanter | 66 | $41K |
Prescribing Profile
Patient Profile
76
Avg Age
54%
Female
2.63
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About